One could envision that prostate cancer diagnosis would involve the use of a relatively small number of markers as a tool for cancer detection, perhaps as a “reflex test” after PSA testing when the patient has an abnormal serum PSA. This evidence concerns the gene KLK3 and Familial prostate cancer.